Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The BigLab...I just found your post on MSN Money and you stated that Abbot Labs would purchase NNLX and add 1 billion dollars /year to their bottom line...Could you explain this in more detail, and if that takes place, what would happen to NNLX shareholders. THanks Parents
Bluefish...so glad you posted today; was concerned because you had not posted in a while. Take good care.
Parents
oh BTW this doctor first researched NNLX and recommended the company to us because of its patents. We became investors because of his DD. He is a lifelong friend.
Not yet...his other investment has not matured so that he has not sold it but he called and indicated he plans on buying 3 million more regardless of the price. I think that is great because that will give long term investors more than 50% of the company...a great hedge against any hostil takeover bid.
Reverse your High and Low headers and you will have it correct: June 17, for example the High was .51 and the Low was
.19;now it is almost July and the accumulation seems to be building again.
Bluefish...in the last run, NNLX seemed to form a base at 18,19,20 and would stay in that range for days as the vol. decreased...then suddenly a big run to .51 and it fell into a new base at .25; now it has stayed in that range for days while the vol. has been decreasing. Today the bid moved to .25 and the ask is .259 on low vol. Are we set up for a large run again?With news,I believe it will land past one dollar; without news, probably .75-.80. Then base at .50; What is your evaluation? Thanks
Yes now I see; thanks Bluefish...BTW do you like to fish...you have an unusual screen name
Blue...I have been amazed as to how you have correctly called the rise in pps of NNLX... I know little re charts and could you explain what you mean by "hugh" and how you arrived at that call. I agree with you but would like to understand your interpretation of the chart...thanks
Parents P.S. GLAD you are not on yahoo; it has become a ZOO with the slimiest/basher posters you can imagine. Kind of nice and quiet over here; no fussing, no strife just good discussion.
MIKE...you did get in at a low price; the price today pales in comparison to what it will be in a year; be grateful, you discovered this treasure before it became hugh. JMHOpinion
Parents
I am SURE that NNLX would not be building a hugh clean room facility without knowledge that orders are forthcoming; this is just plain common sense! And I believe the operations update makes that inference....noting the intense interests from many diverse parties ....have some faith!!
Operations Update from the NNLX website:
ASM Meeting and Operations Update
June 18, 2009:
NanoLogix attended the American Society for Microbiology 109th General Meeting from May 18 – 20, 2009 in Philadelphia, PA. There was tremendous interest in the company's BNP™ technology from corporations involved in diagnostic testing, the pharmaceutical industry, governmental agencies, medical laboratories, environmental organizations, and universities. The BNP™ kits are currently undergoing evaluation by a number of those who demonstrated interest.
Construction of a clean room production facility at our Hubbard, Ohio headquarters is ongoing. Upon completion, BNP kit production will be shifted from our Cincinnati lab to the new facility, with BNP kit production anticipated to begin this summer.
--------------------------------------------------------------------------------
Contact:
NanoLogix, Inc.
Investor Relations
Carol Surrena
Telephone: 330-534-0800
E-mail: Carol@nanologix.com
Copyright 2009 NanoLogix, Inc All Rights Reserved
Oh string I am sorry....the rise today is wonderful but I also am sad for folks I know that will have to pay more for each share. So it is a mixed blessing.
Well I did tell one of our investment group to hurry; he emailed his intention of doubling his shares to 1.5 million.
bid is .23 and ask is .43 at the moment; this is a hugh breakout!!!
ask is .25, bid is .22 at this moment; last price is .22
Now at .21...amazing and next week there will be heavy buying according to individuals we know of. Money is being transferred into ameritrade as we speak...
Rookie...first it was published in abstract form but my understanding is that few investors read the abstract; then it was published in final form in "Letters of Applied Microbiology" in a hard copy form...that is apparently what is being read and investors apparently are responding to that journal article. The full article or paper is in PDF on the NNLX website. I am sure there are many reasons why the pps has increased suddenly but that is a major one.
Thank you so much; I did not know this link even existed and I have bookmarked it; so we skipped 18...amazing...h
In my view, Battelle's paper,[now published] is pushing the share price higher by bringing more exposure of NNLX. I could hardly believed it; I was looking at .175 and at EOD it was .19 Whatever happened to .18...did we just skip it? Thanks
That is my understanding also...but NEOhio...you can always ask Bret for confirmation.
It indeed was NEOhioinvestor... We are all grateful
I think this is a nice forum; now that the website has been somewhat updated, it should attract more investors...Cheers
Thanks aslfS...I get so weary of yahoo especially since they seemingly have no way to verify the IP address of the poster enabling multiple aliases from a single computer. This morning, a first time poster...basher., brought up an issue relevant in 2007, not today...wearisome...
Laughing Out Loud... thanks for updating and, lockshed, I was astonished to click here and discover the drastic and needed changes...thanks and PTL!
NEOhioinvestor...you are now our moderator and have updated this website; Glory...we have a moderator; thanks...Do you reside near NNLX and have you met the CEO...? Any information you could share would be appreciated. Thanks and how did you discover this hidden gem?
I would need to check...I do not think so...not yet but coming soon yes!
That is a hit but we converted when the stock price was about eight cents so it did not hit us too hard. But it made such sense because we anticipate this stock climbing much higher and in fact it is trading between .14 -.15 Oh it did hit .16 today briefly. Now we must wait 3 amd 1/2 more years before we can withdraw more than we put in [you can withdraw your original investment without penalty] So we do not plan on selling those shares although we could sell just not withdraw them.
Actually we have such confidence in NNLX's future and prosperity, we did a Roth conversion...we converted at around 8 cents a share...We have 3 and 1/2 years to wait until we can withdraw all tax free...We also have another account with 1 million...Our group holds over 5 million and with the addition of 400K bringing our total to 5.7 million ..approx. So we are heavily invested...oh you must be reading the yahoo MB...that is where we mainly post...A very active board!
NEO...I am so glad you posted here; we initially purchased high but brought the stock all the way down when BB became CEO; we were and are grateful for the management change and truly believe that this company will greatly prosper and all of us along with it...So now our base is low but yours is also, just 15 pennies from where it is trading and with greater exposure and volume, that is very little in my view..Take care..Parents...
Thanks cashwealth, my friend, - someone mailed me and asked me to post regarding a "potential competitor" and I refused. I forwarded the email to NNLX and as it turned out the "alleged competitor" has no products that could compete with NNLX BNP. Also the company did not even exhibit at the ASM. It all seemed like someone was trying to manipulate and use me to post to scare investors, but I REFUSED and was not gracious to the person at all. Thanks
Cashwealth - did you send me an email at yahoo using the screen name of bd454_70 It is very important that I know if that was you because this person asked me to post for him and I have never had that happen to me before. And I thought it was a trick...please tell me, for if it was you I owe you an apology; thanks
Really easy to google yahoo but the website is www.yahoo.com and then click financials and then enter NNLX.PK and then click on message board on the left. Here is a link to the message board and the quote is under the Asm topic...Bret
s is the five red star rating post; his name is on the post
http://messages.finance.yahoo.com/mb/NNLX.PK
We closed at .15 and there is a hilarious post by Bret Barnhizer at yahoo:
"I am at the ASM. It's going well, good discussions, lots of interest --- the NanoLogix personnel are healthy, good looking, and knowledgable. Wait... we are the NanoLogix personnel and are naturally biased, so ignore that descriptive statement. Internet connections are spotty on the exhibition floor, the coffee is good but the food is not. BNP rules.
Bret"
The part I liked best is "BNP rules" Great things ahead in my view
OPENING PRICE was .15 - then someone sold 100K and dropped the price to .11; now at .13
Great vol. at end of day trading; that indeed is a sign and next week the Conference with Batelle's paper there to confirm all of our technology...This is a fantastic company and how blessed we are to find it.
What is the significance of this?
Consider carefully the Science Advisory Board...We may capture the petri dish market in India before the US and that would be hugh.
Even MORE important is the building of production facility
Press Release Source: NanoLogix, Inc.
NanoLogix Begins Construction of Production Facility for Medical Test Kits
Tuesday April 21, 2009, 9:45 am EDT
Buzz up! Print HUBBARD, Ohio, April 21 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (OTC: NNLX - News) -- NanoLogix Inc. has begun construction on a 2,800 square foot manufacturing facility at its headquarters in Hubbard, Ohio. It will contain a production cleanroom, cold-storage vault, and shipping and receiving area to be used in the fabrication of BNP(TM) Ultra-Fast test kits.
The revolutionary new BNP(TM) kits provide accelerated detection of bacteria and pathogens -- 100 to 600% faster than conventional Petri plate testing. They will have broad applications in Homeland Security, human and veterinary medicine, processing and safety of food, cosmetics and drugs, research and development, and industrial and environmental testing.
One of the foremost bio-defense and biomedical research centers in the U.S. recently found in its tests that the BNP(TM) provided results up to four times faster than current Petri plate methods. Using the BNP(TM) they were able to view anthrax cultures in one-quarter of the time, and bubonic plague (Black Death) cultures in half of the time possible with the best traditional methods. The study appears in the current online issue of Letters in Applied Microbiology. Link to study:
http://nanologix.com/downloads/NNLX_resource_3.pdf
The new facility will replace the company's current limited-production operation at its research and development laboratory in Cincinnati, boosting production capability to thousands of BNP(TM) kits per day. This provides the opportunity for expanded R&D of other NanoLogix products at the Cincinnati lab.
The BNP(TM) kit is based on NanoLogix's revolutionary sandwiched-membrane Petri technology. The company believes the BNP(TM) has a high potential of capturing a significant percentage of the annual multi-billion dollar Petri plate market in both the United States and internationally.
NanoLogix CEO Bret Barnhizer stated: "With the BNP(TM) kits, we believe we are on our way to establishing a new 'gold Standard' for microorganism detection that will have a revolutionary effect on medical testing, diagnosis and treatment. This production facility will enable us to capitalize on our technology and provide product to those who are rapidly becoming aware of the BNP(TM) potential".
The test kits provide users the ability for faster detection of a long list of pathogens, including E-coli, Salmonella, Listeria, Enterobacter, Staphylococcus, Anthrax and Bubonic plague.
In addition to providing ultra-fast viewing of microorganisms normally cultured on standard Petri plates, the BNP(TM) kits can be used to assist in early detection of some of the most dangerous pathogens in the world, including those that pose significant potential threats for use as bio-weapons by terrorists.
The BNP(TM) production operation is expected to create a dozen jobs in the economically depressed Youngstown, Ohio, area, with more to follow as product demand increases.
Other NNLX News:
NanoLogix recently received a substantial royalty payment for 2008 from NutraPharma, a bio-pharmaceutical company with a license on a number of NanoLogix patents.
CEO Bret Barnhizer and Director John Chatterton recently met with U.S. Representative Tim Ryan (Ohio 17th District) in Washington DC for a discussion of Federal programs related to business assistance.
PRESS RELEASE AND NEW WEBSITE; www.nanologix.com
New Weapon in BioDefense Research: NanoLogix Kit Speeds Rapid Diagnostics of Anthrax and Bubonic Plague
Monday April 13, 2009, 9:45 am EDT
Buzz up! Print HUBBARD, Ohio, April 13 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (OTC: NNLX - News) a biotechnology company, is pleased to provide the following information:
An independent study has found that NanoLogix's BNP(TM) Ultra-Fast Identification Technology allows the viewing of anthrax cultures four times faster than conventional methods.
The study, by one of the foremost bio-defense and biomedical research centers in the U.S., appears in the current online issue of Letters in Applied Microbiology. The authors found that NanoLogix's BNP(TM) technology displayed colonies of anthrax in six hours, as contrasted with the fastest traditional methods, which typically take 24 hours.
The study also found that the NanoLogix BNP(TM) technology allowed viewing of cultures of bubonic plague, known historically as the "Black Death", twice as fast as traditional Petri plate methods.
The study, by an independent lab under strict protocols, confirms the value of NanoLogix's breakthrough technology when time is a crucial factor. The BNP(TM) method has proven to be much faster than any other method in the broad field of Petri dish testing.
The authors of the study concluded that the NanoLogix technology could lead to a more rapid assessment of surface sampling and decontamination measures, and could aid in the evaluation of medical countermeasures and treatments.
The study appears in the current online issue of Letters in Applied Microbiology.
Links to study:
http://www3.interscience.wiley.com/journal/122295541/abstract
http://www.nanologix.com/downloads/NNLX%20-%20resource%203.pdf
NanoLogix's BNP(TM) Ultra Fast Identification Technology has applications for fields outside the bio-defense arena as well, including epidemiology, hospital diagnosis, veterinary medicine and food safety.
NanoLogix CEO Bret Barnhizer stated "We are elated with the results of the study and look forward to increased public awareness of the broad capabilities of the BNP(TM) Ultra-Fast kits. We believe that the BNP(TM) sandwiched-membrane is the next evolutionary step in Petri technology and will be the kit of choice whenever faster test results are essential."
The bacteria responsible for Anthrax and Bubonic plague are category A select agents, due to their capacity to cause illness and death. These micro-organisms are a preferred bio-weapon of terrorists. As these agents are highly dangerous all testing was done in a BioSafety Level 3 laboratory (BSL-3). This is protocol required with category A select agents, which can cause serious or potentially lethal disease after inhalation.
The BNP(TM) technology provided similar colony counts for anthrax in 6 hours as obtained with the traditional Petri method in 24 hours. For Bubonic plague, the BNP(TM) colony count in 24 hours was also similar to what the traditional methodology achieved in 48 hours.
In 2001, letters containing anthrax spores were mailed to several news media offices and to the offices of two U.S. Senators, killing five people and infecting 17 others, throwing the nation into a near panic. During the first crucial hours of infection or threat, rapid confirmation of the presence of biological agents can mean the difference between life and death, between a widespread public panic and a smooth containment strategy.
In the event of future attacks such as occurred in 2001, the hope is that the BNP's(TM) ability to assist in determining the threat posed by biologic agents will contribute to a more rapid diagnosis and response.
About NanoLogix
NanoLogix is a biotechnology company focused primarily on medical diagnostics. Its products offer accelerated detection and identification of microorganisms present in infectious and non-infectious human diseases, such as tuberculosis, NTM, pneumonia, HIV/AIDS, cancer, cystic fibrosis, anthrax, and plague. In addition to medical and homeland security applications, NanoLogix technology is applicable in pharmaceutical, industrial, veterinary and environmental testing.
Patents granted to NanoLogix can be used in the areas of applied microbiology, soil microbiology and bioremediation, microbial physiology, molecular biology, pharmacology, pharmaco-kinetics, antibiotic sensitivity, stem-cell research, and bioreactor-based hydrogen generation.
More information on NanoLogix is available at: www.nanologix.com
This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of NanoLogix, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
Contact:
Investor Relations
Carol Surrena
Telephone: 330-534-0800
E-mail: Carol@nanologix.com
Full text of BNP [tm] VALIDATION now posted on NNLX's website:
http://www.nanologixinc.com/